Media Summary: East® User Group Meeting 2016 Featured Presentation Leading the 2016 annual EUGM Bjorn Bornkamp of Novartis explains ... Discover the research being done by IDEAS ESR Marius Thomas, based at Novartis in Switzerland. More videos can be found at ... Identifying the appropriate patient population for an experimental therapy is an essential yet challenging task in clinical research.

Subgroup Analyses In Early Phase - Detailed Analysis & Overview

East® User Group Meeting 2016 Featured Presentation Leading the 2016 annual EUGM Bjorn Bornkamp of Novartis explains ... Discover the research being done by IDEAS ESR Marius Thomas, based at Novartis in Switzerland. More videos can be found at ... Identifying the appropriate patient population for an experimental therapy is an essential yet challenging task in clinical research. This animated video explores some of the potential pitfalls of performing This video is part of the HMP Education content archive and may include previously accredited educational material. While this ... In this introductory video I describe what a

Methods seminar 26/06/2014 by Peter Mahlknecht. So uh you know in the end uh section today session today we want to we have a paper that has a lot of In this video I discuss how to determine if a Michele Cavo, MD, PhD, Bologna University School of Medicine, Bologna, Italy, discusses a number of post hoc Viktor Grünwald, MD, University Hospital Essen, Essen, Germany, shares the efficacy findings of lenvatinib plus pembrolizumab ... Subgroup analysis of the SYNTAX data, how far can you go

Photo Gallery

Subgroup Analyses in Early Phase Clinical Trials - Bjorn Bornkamp, Novartis
Subgroup analyses in early-phase clinical trials
NHLBI ICTR Short Video #2, Subgroup Analyses in Clinical Trials
Subgroup Analyses: Subpar or Sublime? | NEJM Evidence
Evaluating predictive markers and subgroups in clinical trials: Caution and best practices
Overview of Subgroup Analysis
Methods seminar: Advantages and Disadvantages of Subgroup Analyses in Systematic Reviews
Study Design for Early Phase Clinical Trials
Dr  Zehtabchi   EBM   Subgroup Analyses
Evaluating a Subgroup Analysis: Was it Designed Properly?
Subgroup analyses in the HORIZON trial of melflufen plus dexamethasone in R/R myeloma
Subgroup analyses in the CLEAR study of lenvatinib plus pembrolizumab versus sunitinib in RCC
View Detailed Profile
Subgroup Analyses in Early Phase Clinical Trials - Bjorn Bornkamp, Novartis

Subgroup Analyses in Early Phase Clinical Trials - Bjorn Bornkamp, Novartis

East® User Group Meeting 2016 Featured Presentation Leading the 2016 annual EUGM Bjorn Bornkamp of Novartis explains ...

Subgroup analyses in early-phase clinical trials

Subgroup analyses in early-phase clinical trials

Discover the research being done by IDEAS ESR Marius Thomas, based at Novartis in Switzerland. More videos can be found at ...

NHLBI ICTR Short Video #2, Subgroup Analyses in Clinical Trials

NHLBI ICTR Short Video #2, Subgroup Analyses in Clinical Trials

Identifying the appropriate patient population for an experimental therapy is an essential yet challenging task in clinical research.

Subgroup Analyses: Subpar or Sublime? | NEJM Evidence

Subgroup Analyses: Subpar or Sublime? | NEJM Evidence

This animated video explores some of the potential pitfalls of performing

Evaluating predictive markers and subgroups in clinical trials: Caution and best practices

Evaluating predictive markers and subgroups in clinical trials: Caution and best practices

This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...

Overview of Subgroup Analysis

Overview of Subgroup Analysis

In this introductory video I describe what a

Methods seminar: Advantages and Disadvantages of Subgroup Analyses in Systematic Reviews

Methods seminar: Advantages and Disadvantages of Subgroup Analyses in Systematic Reviews

Methods seminar 26/06/2014 by Peter Mahlknecht.

Study Design for Early Phase Clinical Trials

Study Design for Early Phase Clinical Trials

June 26, 2015 "Study Design for

Dr  Zehtabchi   EBM   Subgroup Analyses

Dr Zehtabchi EBM Subgroup Analyses

So uh you know in the end uh section today session today we want to we have a paper that has a lot of

Evaluating a Subgroup Analysis: Was it Designed Properly?

Evaluating a Subgroup Analysis: Was it Designed Properly?

In this video I discuss how to determine if a

Subgroup analyses in the HORIZON trial of melflufen plus dexamethasone in R/R myeloma

Subgroup analyses in the HORIZON trial of melflufen plus dexamethasone in R/R myeloma

Michele Cavo, MD, PhD, Bologna University School of Medicine, Bologna, Italy, discusses a number of post hoc

Subgroup analyses in the CLEAR study of lenvatinib plus pembrolizumab versus sunitinib in RCC

Subgroup analyses in the CLEAR study of lenvatinib plus pembrolizumab versus sunitinib in RCC

Viktor Grünwald, MD, University Hospital Essen, Essen, Germany, shares the efficacy findings of lenvatinib plus pembrolizumab ...

Subgroup analysis of the SYNTAX data, how far can you go

Subgroup analysis of the SYNTAX data, how far can you go

Subgroup analysis of the SYNTAX data, how far can you go